<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.2.1" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
	<title>Comments on: New drug for aggressive prostate cancer the best thing in 70 years</title>
	<link>http://www.askmenhealth.org/blog/prostate/new-drug-for-aggressive-prostate-cancer-the-best-thing-in-70-years</link>
	<description>Recent news and info related to conditions and diseases that could influence men's health.</description>
	<pubDate>Thu, 20 Nov 2008 09:11:10 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2.1</generator>

	<item>
		<title>By: New drug for aggressive prostate cancer the best thing in 70 years &#183; Prostate Cancer</title>
		<link>http://www.askmenhealth.org/blog/prostate/new-drug-for-aggressive-prostate-cancer-the-best-thing-in-70-years#comment-3844</link>
		<author>New drug for aggressive prostate cancer the best thing in 70 years &#183; Prostate Cancer</author>
		<pubDate>Tue, 22 Jul 2008 18:38:09 +0000</pubDate>
		<guid>http://www.askmenhealth.org/blog/prostate/new-drug-for-aggressive-prostate-cancer-the-best-thing-in-70-years#comment-3844</guid>
		<description>[...] Aegon Q net, operating income aeg. wrote an interesting post today onHere&#8217;s a quick excerpt Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years. The new drug Abiraterone could they say potentially treat up to 80% of patients with a deadly form of the disease which is resistant to currently available chemotherapy. Abiraterone works by blocking the hormones which fuel the cancer and is a major step forward in the treatment of end-stage prostate cancer patients. [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] Aegon Q net, operating income aeg. wrote an interesting post today onHere&#8217;s a quick excerpt Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years. The new drug Abiraterone could they say potentially treat up to 80% of patients with a deadly form of the disease which is resistant to currently available chemotherapy. Abiraterone works by blocking the hormones which fuel the cancer and is a major step forward in the treatment of end-stage prostate cancer patients. [&#8230;]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
